Efficacy of sacubitril/valsartan among patients with chronic heart failure with reduced ejection fraction
Objective: Chronic heart failure is one of the leading causes of hospitalization and recurrent admissions among the elderly population worldwide. This study was conducted to determine the efficacy of Sacubitril/Valsartan among heart failure cases with reduced left ventricular ejection fraction. M...
Saved in:
Main Authors: | Madiha Butt, Ayesha Niazi, Zahra Rafique, Nadia Shams, Lubna Meraj, Asma Rauf |
---|---|
Format: | Article |
Language: | English |
Published: |
Rawalpindi Medical University
2024-09-01
|
Series: | Journal of Rawalpindi Medical College |
Online Access: | https://www.journalrmc.com/index.php/JRMC/article/view/2718 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease
by: Seonhwa Lee, et al.
Published: (2020-06-01) -
Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting
by: Charlotte Nordberg Backelin, et al.
Published: (2020-06-01) -
Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
by: David Carballo, et al.
Published: (2020-06-01) -
Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan
by: Simone Mazzetti, et al.
Published: (2020-06-01) -
Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
by: Robert J.H. Miller, et al.
Published: (2022-06-01)